Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation.
J F Keaney Jr, … , A Xu, J A Vita
J F Keaney Jr, … , A Xu, J A Vita
Published July 15, 1996
Citation Information: J Clin Invest. 1996;98(2):386-394. https://doi.org/10.1172/JCI118804.
View: Text | PDF
Research Article Article has an altmetric score of 2

Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation.

  • Text
  • PDF
Abstract

Excess vascular oxidative stress has been linked to impaired endothelium-dependent arterial relaxation in hypercholesterolemia. alpha-Tocopherol (AT) preserves endothelial function in hypercholesterolemia although the mechanism(s) for this protective effect is (are) not known. We examined the tissue-specific effects of AT on oxidized LDL (ox-LDL)-mediated endothelial dysfunction in male New Zealand White rabbits. Animals consumed chow deficient in (< 10 IU/kg) or supplemented with (1,000 IU/kg) AT for 28 d. Exposure of thoracic aortae from AT-deficient animals to ox-LDL (0-500 microg/ml) for 4 h produced dose-dependent inhibition of acetylcholine-mediated relaxation (P < 0.05) while vessels derived from animals consuming AT were resistant to ox-LDL-mediated endothelial dysfunction. Animals consuming AT demonstrated a 100-fold increase in vascular AT content and this was strongly correlated with vessel resistance to endothelial dysfunction from ox-LDL (R = 0.67; P = 0.0014). These results were not explained by an effect of AT on ox-LDL-mediated cytotoxicity by LDH assay or scanning electron microscopy. Vascular incorporation of AT did produce resistance to endothelial dysfunction from protein kinase C stimulation, an event that has been implicated in the vascular response to ox-LDL. Human aortic endothelial cells loaded with AT also demonstrated resistance to protein kinase C stimulation by both phorbol ester and ox-LDL. Thus, these data indicate that enrichment of vascular tissue with AT protects the vascular endothelium from ox-LDL-mediated dysfunction, at least in part, through the inhibition of protein kinase C stimulation. These findings suggest one potential mechanism for the observed beneficial effect of AT in preventing the clinical expression of coronary artery disease that is distinct from the antioxidant protection of LDL.

Authors

J F Keaney Jr, Y Guo, D Cunningham, G T Shwaery, A Xu, J A Vita

×

Total citations by year

Year: 2024 2022 2021 2020 2019 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1995 1994 Total
Citations: 1 1 1 1 2 1 2 3 1 3 2 5 4 10 2 7 13 11 5 16 21 14 17 9 3 1 1 157
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2008 (10)

Title and authors Publication Year
Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities
SR Thomas, PK Witting, GR Drummond
Antioxidants & Redox Signaling 2008
Modern Nutrition
K LaPoint, M McIntosh
Handbook of Nutrition in the Aged, Fourth Edition 2008
Impaired graft healing due to hypercholesterolemia is prevented by dietary supplementation with α-tocopherol
K Miyazaki, SM Colles, LM Graham
Journal of Vascular Surgery 2008
Vitamins and cardiovascular disease
S Honarbakhsh, M Schachter
British Journal of Nutrition 2008
Does reversal of oxidative stress and inflammation provide vascular protection?
KK Koh, PC Oh, MJ Quon
Cardiovascular Research 2008
Genetic polymorphisms as determinants for disease-preventive effects of vitamin E
JM Zingg, A Azzi, M Meydani
Nutrition Reviews 2008
Protective effects of a compound herbal extract (Tong Xin Luo) on free fatty acid induced endothelial injury: implications of antioxidant system
L Zhang, Y Wu, Z Jia, Y Zhang, HY Shen, XL Wang
BMC complementary and alternative medicine 2008
Free Radicals in Ophthalmic Disorders
M Miranda, F Bosch-Morell, M Muriach, J Barcia, F Romero, M Diaz-Llopis, A Messeguer
Free Radicals in Ophthalmic Disorders 2008
Vitamin E in Human Health and Disease
MW Clarke, JR Burnett, KD Croft
Critical Reviews in Clinical Laboratory Sciences 2008
Antiangiogenic Agents in Cancer Therapy
BA Teicher, LM Ellis
2008

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
27 readers on Mendeley
See more details